Marco Valvano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marco Valvano has a total of 193 co-authors. Here are the top co-authors by number of shared publications:
- Giovanni Latella
Department of Life, Health & Environmental Sciences, University of L’Aquila, 67100 L’Aquila, Italy
16 shared publications - Angelo Viscido
Department of Life, Health, and Environmental Sciences, Division of Gastroenterology, Hepatology, and Nutrition, University of L’Aquila, Piazza S. Tommasi, 1, Coppito, 67100 L’Aquila, Italy
12 shared publications Antonio Vinci
Hospital Health Management Area, Local Health Authority „Roma 1”, Roma, Italy
7 shared publications- Antonio Vinci
Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy
7 shared publications - Filippo Vernia
Department of Life, Health, and Environmental Sciences, Division of Gastroenterology, Hepatology, and Nutrition, University of L’Aquila, Piazza S. Tommasi, 1, Coppito, 67100 L’Aquila, Italy
7 shared publications Gianpiero Stefanelli
Gastroenterology Unit, Ente Ospedaliero Galliera, Via delle Mura Cappuccine, 14, 16128Genova, Italy
6 shared publications
Latest Publications
- Open Access
Current Evidence on Endoscopic Biliary Drainage in the Era of Surgically Altered Anatomy: A Narrative Review
Endoscopic retrograde cholangiopancreatography (ERCP) remains the reference standard for biliary drainage, yet it fails in up to 15% of cases, most notably when a surgically altered anatomy (SAA) is present. The expanding use of bariatric and oncologic gastrointestinal surgery has increased the number of patients in whom the papilla is displaced, unreachable, or replaced by a biliodigestive anastomosis, making conventional access difficult or impossible. This narrative review appraises the current evidence on endoscopic biliary drainage in SAA, focusing on procedural efficacy, anatomical peculiarities, adverse-event profiles and technical considerations to guide clinical decision-making. Available strategies include luminal techniques, duodenoscope-assisted ERCP, forward-viewing (cap-assisted colonoscope) ERCP, and enteroscope-assisted ERCP, as well as endoscopic ultrasound-guided biliary drainage (EUS-BD), encompassing EUS-guided hepaticogastrostomy, EUS-guided antegrade stenting, EUS-guided rendezvous and EUS-directed transgastric/transenteric ERCP (EDGE/EDEE), and laparoscopic-assisted ERCP (LA-ERCP). No single approach is universally superior and available comparative data is mainly retrospective and affected by major selection bias. Technique selection should be tailored to the reconstruction type, indication (benign vs. malignant), limb length, expected survival, and local expertise, ideally within a multidisciplinary, high-volume setting. Adequately powered randomized trials incorporating quality-of-life and cost-effectiveness endpoints are still needed to define the optimal first-line strategy. This literature review encompasses the multiple strategies to achieve biliary drainage in surgically altered anatomy, highlighting strengths and weaknesses of each technique, as well as the preferred approach for each type of anatomical reconstruction.
Open AccessCurrent Evidence on Endoscopic Biliary Drainage in the Era of Surgically Altered Anatomy: A Narrative Review
Endoscopic retrograde cholangiopancreatography (ERCP) remains the reference standard for biliary drainage, yet it fails in up to 15% of cases, most notably when a surgically altered anatomy (SAA) is present. The expanding use of bariatric and oncologic gastrointestinal surgery has increased the number of patients in whom the papilla is displaced, unreachable, or replaced by a biliodigestive anastomosis, making conventional access difficult or impossible. This narrative review appraises the current evidence on endoscopic biliary drainage in SAA, focusing on procedural efficacy, anatomical peculiarities, adverse-event profiles and technical considerations to guide clinical decision-making. Available strategies include luminal techniques, duodenoscope-assisted ERCP, forward-viewing (cap-assisted colonoscope) ERCP, and enteroscope-assisted ERCP, as well as endoscopic ultrasound-guided biliary drainage (EUS-BD), encompassing EUS-guided hepaticogastrostomy, EUS-guided antegrade stenting, EUS-guided rendezvous and EUS-directed transgastric/transenteric ERCP (EDGE/EDEE), and laparoscopic-assisted ERCP (LA-ERCP). No single approach is universally superior and available comparative data is mainly retrospective and affected by major selection bias. Technique selection should be tailored to the reconstruction type, indication (benign vs. malignant), limb length, expected survival, and local expertise, ideally within a multidisciplinary, high-volume setting. Adequately powered randomized trials incorporating quality-of-life and cost-effectiveness endpoints are still needed to define the optimal first-line strategy. This literature review encompasses the multiple strategies to achieve biliary drainage in surgically altered anatomy, highlighting strengths and weaknesses of each technique, as well as the preferred approach for each type of anatomical reconstruction.
- Open Access
- 14 April 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (8) , 1161
Diagnostic Performance of a Deep Learning-Based Tool for the Detection and Staging of Rectal Cancers on Endoscopic Ultrasound: Prospective Study
Background: Loco-regional staging of rectal cancer relies on MRI and rectal EUS (R-EUS). In situ and T1 tumors may be candidates for endoscopic resection, and R-EUS enables reliable differentiation among early-stage tumors (Tis, T1, T2), a distinction that MRI cannot consistently provide. This prospective pilot study aimed to evaluate the predictive performance of a deep learning (DL) tool for detecting and staging rectal tumors on R-EUS. Methods: The DL tool uses a convolutional neural network for image segmentation and classification. Performance in lesion segmentation was assessed using the Dice Similarity Coefficient (DSC) and F1-score. The model was first evaluated for its ability to differentiate in situ and T1 tumors from T2/T3 lesions, and then for distinguishing Tis from other stages (T1, T2, T3). Results: Fifty patients were enrolled. The median DSC for tumor segmentation was 0.65 (IQR 0.17). Tumor detection showed an accuracy of 0.77, precision of 0.85, recall of 0.77, and F1-score of 0.81. In distinguishing Tis/T1 from T2/T3 tumors, the model achieved an accuracy of 0.64, precision of 0.88, recall of 0.64, and F1-score of 0.74. For distinguishing Tis from T1, T2, and T3 lesions, the accuracy was 0.80, precision 0.83, recall 0.89, and F1-score 0.86. Mesorectal lymph node segmentation showed a median DSC of 0.62 (IQR 0.17). Conclusions: The DL tool shows promise for aiding operators in identifying rectal lesions suitable for endoscopic resection. The semi-supervised training approach reduces manual segmentation burden and achieves performance comparable to expert physicians.
- 14 April 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (8) , 1161
Open AccessDiagnostic Performance of a Deep Learning-Based Tool for the Detection and Staging of Rectal Cancers on Endoscopic Ultrasound: Prospective Study
Background: Loco-regional staging of rectal cancer relies on MRI and rectal EUS (R-EUS). In situ and T1 tumors may be candidates for endoscopic resection, and R-EUS enables reliable differentiation among early-stage tumors (Tis, T1, T2), a distinction that MRI cannot consistently provide. This prospective pilot study aimed to evaluate the predictive performance of a deep learning (DL) tool for detecting and staging rectal tumors on R-EUS. Methods: The DL tool uses a convolutional neural network for image segmentation and classification. Performance in lesion segmentation was assessed using the Dice Similarity Coefficient (DSC) and F1-score. The model was first evaluated for its ability to differentiate in situ and T1 tumors from T2/T3 lesions, and then for distinguishing Tis from other stages (T1, T2, T3). Results: Fifty patients were enrolled. The median DSC for tumor segmentation was 0.65 (IQR 0.17). Tumor detection showed an accuracy of 0.77, precision of 0.85, recall of 0.77, and F1-score of 0.81. In distinguishing Tis/T1 from T2/T3 tumors, the model achieved an accuracy of 0.64, precision of 0.88, recall of 0.64, and F1-score of 0.74. For distinguishing Tis from T1, T2, and T3 lesions, the accuracy was 0.80, precision 0.83, recall 0.89, and F1-score 0.86. Mesorectal lymph node segmentation showed a median DSC of 0.62 (IQR 0.17). Conclusions: The DL tool shows promise for aiding operators in identifying rectal lesions suitable for endoscopic resection. The semi-supervised training approach reduces manual segmentation burden and achieves performance comparable to expert physicians.
- Open Access
- 24 February 2026
- Published by MDPI AG in Gastrointestinal Disorders
- Vol. 8 (1) , 13
The Evolving Landscape of Advanced Therapies in Inflammatory Bowel Disease: Current Evidence and Emerging Targets
Background: Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic conditions that affect the gastrointestinal tract. Since the initial approval of infliximab (IFX), a monoclonal antibody targeting TNF-α, numerous novel therapeutic targets have been identified, and many new therapies have been approved for the treatment of IBD. Methods: We conducted a narrative review of the literature using major biomedical databases, including EMBASE, Scopus, PubMed, CENTRAL, and ClinicalTrials.gov (last search date: 10 December 2025). Results: This review summarizes the current evidence on therapies approved for IBD (both CD and UC) and provides an overview of investigational agents currently being evaluated in ongoing phase II and III clinical trials. Conclusions: Moderate optimism arises from the expanding array of therapeutic targets under investigation and from emerging treatment strategies. However, only through a deeper understanding of the pathophysiological mechanisms underlying IBD will substantial improvements in treatment outcomes be achieved for conditions that continue to impose a significant burden on patients’ quality of life.
- 24 February 2026
- Published by MDPI AG in Gastrointestinal Disorders
- Vol. 8 (1) , 13
Open AccessThe Evolving Landscape of Advanced Therapies in Inflammatory Bowel Disease: Current Evidence and Emerging Targets
Background: Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic conditions that affect the gastrointestinal tract. Since the initial approval of infliximab (IFX), a monoclonal antibody targeting TNF-α, numerous novel therapeutic targets have been identified, and many new therapies have been approved for the treatment of IBD. Methods: We conducted a narrative review of the literature using major biomedical databases, including EMBASE, Scopus, PubMed, CENTRAL, and ClinicalTrials.gov (last search date: 10 December 2025). Results: This review summarizes the current evidence on therapies approved for IBD (both CD and UC) and provides an overview of investigational agents currently being evaluated in ongoing phase II and III clinical trials. Conclusions: Moderate optimism arises from the expanding array of therapeutic targets under investigation and from emerging treatment strategies. However, only through a deeper understanding of the pathophysiological mechanisms underlying IBD will substantial improvements in treatment outcomes be achieved for conditions that continue to impose a significant burden on patients’ quality of life.
- Open Access
- 9 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 522
Endoscopic Ultrasound-Guided Lumen-Apposing Metal Stent Drainage in Benign Pancreatobiliary and Gastrointestinal Disease: Evolving Techniques and Clinical Outcomes
Interventional endoscopic ultrasound (EUS) has become a cornerstone in the management of malignant pancreatobiliary diseases, offering minimally invasive alternatives to traditional surgical approaches. More recently, accumulating evidence supports its expanding role in the treatment of benign pancreatobiliary conditions, including acute cholecystitis and pancreatitis, benign gastric outlet obstruction, and scenarios involving altered gastrointestinal anatomy. This narrative review provides an overview of key EUS-guided drainage techniques utilizing lumen-apposing metal stents (LAMSs) in benign settings. It focuses on procedures such as EUS-guided gallbladder drainage, drainage of abdominal collections, EUS-directed transgastric ERCP (EDGE), and EUS-gastroenterostomy. These interventions have demonstrated high technical and clinical success rates, favorable safety profiles, and expanding indications, particularly among patients who are poor surgical candidates. This review highlights evolving techniques, clinical outcomes, and the impact of device innovations on procedural efficacy and safety.
- 9 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (4) , 522
Open AccessEndoscopic Ultrasound-Guided Lumen-Apposing Metal Stent Drainage in Benign Pancreatobiliary and Gastrointestinal Disease: Evolving Techniques and Clinical Outcomes
Interventional endoscopic ultrasound (EUS) has become a cornerstone in the management of malignant pancreatobiliary diseases, offering minimally invasive alternatives to traditional surgical approaches. More recently, accumulating evidence supports its expanding role in the treatment of benign pancreatobiliary conditions, including acute cholecystitis and pancreatitis, benign gastric outlet obstruction, and scenarios involving altered gastrointestinal anatomy. This narrative review provides an overview of key EUS-guided drainage techniques utilizing lumen-apposing metal stents (LAMSs) in benign settings. It focuses on procedures such as EUS-guided gallbladder drainage, drainage of abdominal collections, EUS-directed transgastric ERCP (EDGE), and EUS-gastroenterostomy. These interventions have demonstrated high technical and clinical success rates, favorable safety profiles, and expanding indications, particularly among patients who are poor surgical candidates. This review highlights evolving techniques, clinical outcomes, and the impact of device innovations on procedural efficacy and safety.
- Open Access
- 5 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 490
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study
Background/Objectives: Adequate bowel preparation (BP) is crucial for effective colorectal cancer (CRC) surveillance in ulcerative colitis (UC). While active inflammation is known to negatively impact cleansing, data regarding predictors of BP quality specifically in UC patients with inactive disease remain limited. This study aimed to investigate risk factors for inadequate BP in UC patients in clinical/endoscopic remission and to compare the efficacy of 1L-PEG-ASC versus 2L-PEG regimens. Methods: A multicentric, retrospective, cohort study was conducted across eight Italian centers. Consecutive adult outpatients with UC undergoing colonoscopy between January-2021 and December-2022 who were in endoscopic and clinical remission were included. Boston Bowel Preparation Scale (BBPS) was assessed in patients undergoing 1L-PEG-ASC or 2L-PEG bowel preparation. Univariable and multivariable logistic regression analyses were performed to identify risk factors for inadequate BP and compare outcomes between PEG regimens. Results: A total of 379 patients were included (58% M, mean age 52.3 ± 15.4 years). The overall rate of adequate BP was 90.5%. Traditional risk factors, including demographic, clinical, and endoscopic characteristics, were not predictive of inadequate preparation in this remission cohort. Comparing regimens, 1L-PEG-ASC yielded significantly higher median total BBPS scores compared to 2L-PEG (8 [IQR 7–9] vs. 6 [IQR 6–8]; p < 0.001) and a higher exam completion rate (99.5% vs. 95.7%; p = 0.02), although the difference in adequate BP rates did not reach statistical significance (92.6% vs. 87.7%; p = 0.12). Multivariable analysis confirmed that 2L-PEG was independently associated with lower odds of achieving higher BBPS scores (OR 0.30; 95% CI 0.20–0.45). Conclusions: In UC patients with clinical and endoscopic remission, BP adequacy rates are high and comparable to the general population, suggesting that traditional IBD-related risk factors are less relevant in the absence of active inflammation. However, the 1L-PEG-ASC regimen demonstrated superior cleansing quality and exam completion rates compared to 2L-PEG. These findings support the prioritization of 1L-PEG-ASC to optimize mucosal visualization during CRC surveillance in this population.
- 5 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 490
Open AccessRisk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study
Background/Objectives: Adequate bowel preparation (BP) is crucial for effective colorectal cancer (CRC) surveillance in ulcerative colitis (UC). While active inflammation is known to negatively impact cleansing, data regarding predictors of BP quality specifically in UC patients with inactive disease remain limited. This study aimed to investigate risk factors for inadequate BP in UC patients in clinical/endoscopic remission and to compare the efficacy of 1L-PEG-ASC versus 2L-PEG regimens. Methods: A multicentric, retrospective, cohort study was conducted across eight Italian centers. Consecutive adult outpatients with UC undergoing colonoscopy between January-2021 and December-2022 who were in endoscopic and clinical remission were included. Boston Bowel Preparation Scale (BBPS) was assessed in patients undergoing 1L-PEG-ASC or 2L-PEG bowel preparation. Univariable and multivariable logistic regression analyses were performed to identify risk factors for inadequate BP and compare outcomes between PEG regimens. Results: A total of 379 patients were included (58% M, mean age 52.3 ± 15.4 years). The overall rate of adequate BP was 90.5%. Traditional risk factors, including demographic, clinical, and endoscopic characteristics, were not predictive of inadequate preparation in this remission cohort. Comparing regimens, 1L-PEG-ASC yielded significantly higher median total BBPS scores compared to 2L-PEG (8 [IQR 7–9] vs. 6 [IQR 6–8]; p < 0.001) and a higher exam completion rate (99.5% vs. 95.7%; p = 0.02), although the difference in adequate BP rates did not reach statistical significance (92.6% vs. 87.7%; p = 0.12). Multivariable analysis confirmed that 2L-PEG was independently associated with lower odds of achieving higher BBPS scores (OR 0.30; 95% CI 0.20–0.45). Conclusions: In UC patients with clinical and endoscopic remission, BP adequacy rates are high and comparable to the general population, suggesting that traditional IBD-related risk factors are less relevant in the absence of active inflammation. However, the 1L-PEG-ASC regimen demonstrated superior cleansing quality and exam completion rates compared to 2L-PEG. These findings support the prioritization of 1L-PEG-ASC to optimize mucosal visualization during CRC surveillance in this population.
- Open Access
- 26 November 2025
- Published by MDPI AG in Gastrointestinal Disorders
- Vol. 7 (4) , 75
Endobiliary Radiofrequency Ablation: Principles, Technique, and Evidence in Cholangiocarcinoma
Unresectable extrahepatic cholangiocarcinoma remains a challenging malignancy with limited therapeutic options and poor prognosis. In this setting, effective and durable biliary drainage is crucial to prevent cholangitis, allow timely initiation and maintenance of systemic therapy, and ultimately improve survival. Endobiliary radiofrequency ablation (RFA) has emerged as a promising adjunct to biliary stenting, aimed at delaying tumor ingrowth and prolonging stent patency through localized thermal ablation of malignant tissue. Several studies have reported longer stent patency and, in some cases, improved survival with RFA plus stenting compared with stenting alone. However, the literature remains heterogeneous, and recent high-quality trials have yielded conflicting results, highlighting the need for further standardization of technique and patient selection. This narrative review summarizes the current evidence on the role of endobiliary RFA in unresectable cholangiocarcinoma, with particular emphasis on mechanism of action, endoscopic technique and oncologic outcomes.
- 26 November 2025
- Published by MDPI AG in Gastrointestinal Disorders
- Vol. 7 (4) , 75
Open AccessEndobiliary Radiofrequency Ablation: Principles, Technique, and Evidence in Cholangiocarcinoma
Unresectable extrahepatic cholangiocarcinoma remains a challenging malignancy with limited therapeutic options and poor prognosis. In this setting, effective and durable biliary drainage is crucial to prevent cholangitis, allow timely initiation and maintenance of systemic therapy, and ultimately improve survival. Endobiliary radiofrequency ablation (RFA) has emerged as a promising adjunct to biliary stenting, aimed at delaying tumor ingrowth and prolonging stent patency through localized thermal ablation of malignant tissue. Several studies have reported longer stent patency and, in some cases, improved survival with RFA plus stenting compared with stenting alone. However, the literature remains heterogeneous, and recent high-quality trials have yielded conflicting results, highlighting the need for further standardization of technique and patient selection. This narrative review summarizes the current evidence on the role of endobiliary RFA in unresectable cholangiocarcinoma, with particular emphasis on mechanism of action, endoscopic technique and oncologic outcomes.
- Open Access
- 14 October 2025
- Published by MDPI AG in Preprints.org
Endobiliary Radiofrequency Ablation: Principles, Technique, and Evidence in Cholangiocarcinoma
Endobiliary radiofrequency ablation (RFA) has emerged as a promising adjunct to biliary stenting in the palliative management of unresectable extrahepatic cholangiocarcinoma. By generating localized thermal injury through a high-frequency alternating current (400–500 kHz) delivered via an intraductal electrode, RFA induces coagulative necrosis of malignant tissue, aiming to delay tumor ingrowth, maintain ductal patency, and improve quality of life. The procedure can be performed during endoscopic retrograde cholangiopancreatography or percutaneously, using bipolar probes advanced over a guidewire under fluoroscopic control. Technical success depends on adequate positioning of the electrodes within the stricture, correct energy settings (7–10 W for 60–120 s), and appropriate stent selection. Preclinical studies demonstrated controlled necrosis extending through the bile-duct wall, while clinical investigations have evaluated its impact on outcomes. Early retrospective series and several randomized controlled trials showed that RFA combined with stenting prolongs stent patency and, in selected subgroups, improves survival compared with stenting alone, without increasing the overall rate of complications. Meta-analyses have confirmed a consistent benefit in stent function and a moderate survival advantage, particularly in distal malignant strictures, although results remain heterogeneous due to differences in technique, patient selection, and stent type. The most frequent adverse events are cholangitis, pancreatitis, and acute cholecystitis. Overall, endobiliary RFA is a safe, technically feasible, and clinically relevant option to enhance biliary drainage in advanced cholangiocarcinoma. Standardization of procedural parameters and prospective trials are still needed to better define its therapeutic role and identify patients most likely to benefit.
- 14 October 2025
- Published by MDPI AG in Preprints.org
Open AccessEndobiliary Radiofrequency Ablation: Principles, Technique, and Evidence in Cholangiocarcinoma
Endobiliary radiofrequency ablation (RFA) has emerged as a promising adjunct to biliary stenting in the palliative management of unresectable extrahepatic cholangiocarcinoma. By generating localized thermal injury through a high-frequency alternating current (400–500 kHz) delivered via an intraductal electrode, RFA induces coagulative necrosis of malignant tissue, aiming to delay tumor ingrowth, maintain ductal patency, and improve quality of life. The procedure can be performed during endoscopic retrograde cholangiopancreatography or percutaneously, using bipolar probes advanced over a guidewire under fluoroscopic control. Technical success depends on adequate positioning of the electrodes within the stricture, correct energy settings (7–10 W for 60–120 s), and appropriate stent selection. Preclinical studies demonstrated controlled necrosis extending through the bile-duct wall, while clinical investigations have evaluated its impact on outcomes. Early retrospective series and several randomized controlled trials showed that RFA combined with stenting prolongs stent patency and, in selected subgroups, improves survival compared with stenting alone, without increasing the overall rate of complications. Meta-analyses have confirmed a consistent benefit in stent function and a moderate survival advantage, particularly in distal malignant strictures, although results remain heterogeneous due to differences in technique, patient selection, and stent type. The most frequent adverse events are cholangitis, pancreatitis, and acute cholecystitis. Overall, endobiliary RFA is a safe, technically feasible, and clinically relevant option to enhance biliary drainage in advanced cholangiocarcinoma. Standardization of procedural parameters and prospective trials are still needed to better define its therapeutic role and identify patients most likely to benefit.
- Open Access
- 26 September 2025
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 34 (3) , 390-399
Pancreatic Enzyme Replacement Therapy: Not Only in Chronic Pancreatitis
The therapeutic application of Pancrelipase spans several key gastroenterological conditions, ranging from chronic pancreatitis to genetic disorders such as cystic fibrosis. Consequently, pancreatic enzyme replacement therapy (PERT) is applicable in a variety of clinical settings, managing pancreatic insufficiency. Beyond chronic pancreatitis, PERT has also shown effectiveness in addressing malabsorption associated with pancreatic surgery, gastrointestinal malignancies, and various dysmetabolic conditions. This review aims to provide a comprehensive overview of the therapeutic applications of PERT and its clinical role in managing both surgical and non-surgical conditions, beyond chronic pancreatitis. PERT has proven crucial in improving patient outcomes, addressing gastrointestinal symptoms, and supporting long-term health in patients with pancreatic insufficiency. While more research, particularly from randomized controlled trials, is required to optimize dosing strategies and establish standardized PERT protocols, clinicians should consider tailoring PERT to individual patient needs based on the available evidence across various clinical scenarios.
- 26 September 2025
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 34 (3) , 390-399
Open AccessPancreatic Enzyme Replacement Therapy: Not Only in Chronic Pancreatitis
The therapeutic application of Pancrelipase spans several key gastroenterological conditions, ranging from chronic pancreatitis to genetic disorders such as cystic fibrosis. Consequently, pancreatic enzyme replacement therapy (PERT) is applicable in a variety of clinical settings, managing pancreatic insufficiency. Beyond chronic pancreatitis, PERT has also shown effectiveness in addressing malabsorption associated with pancreatic surgery, gastrointestinal malignancies, and various dysmetabolic conditions. This review aims to provide a comprehensive overview of the therapeutic applications of PERT and its clinical role in managing both surgical and non-surgical conditions, beyond chronic pancreatitis. PERT has proven crucial in improving patient outcomes, addressing gastrointestinal symptoms, and supporting long-term health in patients with pancreatic insufficiency. While more research, particularly from randomized controlled trials, is required to optimize dosing strategies and establish standardized PERT protocols, clinicians should consider tailoring PERT to individual patient needs based on the available evidence across various clinical scenarios.
- Open Access
The Relationship Between Nutritional Status, Micronutrient Deficiency, and Disease Activity in IBD Patients: A Multicenter Cross-Sectional Study
Background and aim: Inflammatory bowel diseases (IBD) are chronic conditions that affect the gastrointestinal tract. The chronic inflammatory state promotes a catabolic environment that contributes to undernutrition, while mucosal damage often impairs nutrient absorption. The aim of this study is to evaluate the relationship between nutritional status—including micronutrient deficiencies—and clinical as well as laboratoristics disease activity in a cohort of patients with IBD. Methods: This is a cross-sectional study conducted across three care centers in Italy. Baseline data, clinical disease activity, and laboratory test results were collected. Micronutrient evaluation included measurements of iron, ferritin, vitamin B12, vitamin D, and folate. In addition, hemoglobin and albumin levels were assessed. Pearson correlation analysis was performed to explore the relationship between disease activity and nutritional status. Additionally, receiver operating characteristics (ROC) analysis were performed to identify patients with active diseases. Results: 110 IBD patients (40 Crohn Disease; 70 Ulcerative Colitis) were included. The serum level of Hb, iron, ferritin and vitamin D was different among the active and inactive group (p: 0.007; p: 0.001; p: 0.005; p: 0.003) while no difference was found among the other micronutrients evaluated (folic acid, vitamin B12) and albumin. Iron and vitamin D levels demonstrated the highest accuracy in the ROC analysis, with Area Under the Curve (AUC) of 0.76 (p < 0.001) and 0.68 (p = 0.013), respectively. Vitamin D and Ferritin showed the better performance (based on calprotectin levels). However, their AUC were sub-optimal (AUC 0.68; p < 0.001; AUC 0.66; p = 0.19. Conclusions: Hemoglobin, iron, ferritin, and vitamin D were associated with disease activity status. However, despite this correlation, their accuracy in discriminating between active and inactive disease appeared to be suboptimal. Folic acid, vitamin B12, and albumin showed poor concordance with disease activity status.
Open AccessThe Relationship Between Nutritional Status, Micronutrient Deficiency, and Disease Activity in IBD Patients: A Multicenter Cross-Sectional Study
Background and aim: Inflammatory bowel diseases (IBD) are chronic conditions that affect the gastrointestinal tract. The chronic inflammatory state promotes a catabolic environment that contributes to undernutrition, while mucosal damage often impairs nutrient absorption. The aim of this study is to evaluate the relationship between nutritional status—including micronutrient deficiencies—and clinical as well as laboratoristics disease activity in a cohort of patients with IBD. Methods: This is a cross-sectional study conducted across three care centers in Italy. Baseline data, clinical disease activity, and laboratory test results were collected. Micronutrient evaluation included measurements of iron, ferritin, vitamin B12, vitamin D, and folate. In addition, hemoglobin and albumin levels were assessed. Pearson correlation analysis was performed to explore the relationship between disease activity and nutritional status. Additionally, receiver operating characteristics (ROC) analysis were performed to identify patients with active diseases. Results: 110 IBD patients (40 Crohn Disease; 70 Ulcerative Colitis) were included. The serum level of Hb, iron, ferritin and vitamin D was different among the active and inactive group (p: 0.007; p: 0.001; p: 0.005; p: 0.003) while no difference was found among the other micronutrients evaluated (folic acid, vitamin B12) and albumin. Iron and vitamin D levels demonstrated the highest accuracy in the ROC analysis, with Area Under the Curve (AUC) of 0.76 (p < 0.001) and 0.68 (p = 0.013), respectively. Vitamin D and Ferritin showed the better performance (based on calprotectin levels). However, their AUC were sub-optimal (AUC 0.68; p < 0.001; AUC 0.66; p = 0.19. Conclusions: Hemoglobin, iron, ferritin, and vitamin D were associated with disease activity status. However, despite this correlation, their accuracy in discriminating between active and inactive disease appeared to be suboptimal. Folic acid, vitamin B12, and albumin showed poor concordance with disease activity status.
- Open Access
- 3 July 2025
- Published by Bentham Science Publishers Ltd. in Reviews on Recent Clinical Trials
- Vol. 20, 1-9
Inter-rater Reliability and Accuracy of NBI Score for Activity Evaluation in Ulcerative Colitis
Background: Colonoscopy is a critical tool for the management of Ulcerative Colitis (UC). In this study, we aim to explore the accuracy of Virtual Chromoendoscopy (VCE) using Narrow Banding Imaging (NBI), and magnification using Near Focus (NF) for a better definition of endoscopic inflammation grade in UC patients compared to standard white light (WL) endoscopy alone. Methods: This is a non-randomized prospective study including all the patients who underwent a colonoscopy (for any reason) between April and September 2023 (with protocol number n. 60/2019.20). During the endoscopic evaluation, at least one image with white light - evaluated using the Mayo Endoscopic Score (MES), one image with NBI, one image with NBI plus NF, and a biopsy were obtained in each colonic tract (cecum, ascending colon, transverse colon, descending colon, sigmoid colon, and rectum). All the stored images were evaluated by three endoscopists separately and compared with the results of the histological evaluation. Results: A total of 31 UC patients were included. The inter-rater reliability concerning the different scores used (MES, NBI score, and NBI plus NF score), which was evaluated with Cohen';s kappa coefficient, was good for the MES, good to excellent for the NBI score, and good for the NBI plus NF score. The concordance between histological evaluation (using the Nancy Index) and the MES was unsatisfactory for all the endoscopists, while the concordance between the NBI evaluation score and the Nancy Index was good to excellent. Conclusion: The results in the present study suggest that the new endoscopic technologies could be useful to better define disease activity in IBD patients driving better therapeutic strategy.
- 3 July 2025
- Published by Bentham Science Publishers Ltd. in Reviews on Recent Clinical Trials
- Vol. 20, 1-9
Open AccessInter-rater Reliability and Accuracy of NBI Score for Activity Evaluation in Ulcerative Colitis
Background: Colonoscopy is a critical tool for the management of Ulcerative Colitis (UC). In this study, we aim to explore the accuracy of Virtual Chromoendoscopy (VCE) using Narrow Banding Imaging (NBI), and magnification using Near Focus (NF) for a better definition of endoscopic inflammation grade in UC patients compared to standard white light (WL) endoscopy alone. Methods: This is a non-randomized prospective study including all the patients who underwent a colonoscopy (for any reason) between April and September 2023 (with protocol number n. 60/2019.20). During the endoscopic evaluation, at least one image with white light - evaluated using the Mayo Endoscopic Score (MES), one image with NBI, one image with NBI plus NF, and a biopsy were obtained in each colonic tract (cecum, ascending colon, transverse colon, descending colon, sigmoid colon, and rectum). All the stored images were evaluated by three endoscopists separately and compared with the results of the histological evaluation. Results: A total of 31 UC patients were included. The inter-rater reliability concerning the different scores used (MES, NBI score, and NBI plus NF score), which was evaluated with Cohen';s kappa coefficient, was good for the MES, good to excellent for the NBI score, and good for the NBI plus NF score. The concordance between histological evaluation (using the Nancy Index) and the MES was unsatisfactory for all the endoscopists, while the concordance between the NBI evaluation score and the Nancy Index was good to excellent. Conclusion: The results in the present study suggest that the new endoscopic technologies could be useful to better define disease activity in IBD patients driving better therapeutic strategy.